Decreased adiponectin levels are critically involved in obesity- and diabetes-related liver tumorigenesis [18, 32] Saroglitazar treatment has increased the adiponectin levels, so this may be one mechanism for preventing liver tumorigenesis. Here, ADIPOQ is linked to diabetes mellitus.